Skip to main content

Advertisement

Log in

Pregnancy in patients with systemic lupus erythematosus: a systematic review

  • Review
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Systemic lupus erythematosus (SLE)—a most common disorder in women of reproductive age—has been described to be associated with adverse pregnancy outcomes. Despite the increased health risks for the mother (preeclampsia, lupus flare, arterial hypertension, gestational diabetes mellitus and thrombotic risk when antiphospholipid antibodies are present) and fetus (miscarriage, stillbirth, premature birth, intrauterine growth restriction and neonatal lupus), the majority of patients can deliver healthy neonates. With appropriate management by a multidisciplinary team, composing rheumatologists, obstetricians and neonatologists, women with SLE can achieve better pregnancy outcomes by monitoring associated predictive indicators, raising major concern for severe complications and somewhat early delivery if necessary. In this review, we summarize the latest advances in secondary infertility and pregnancy-related risk perception for lupus patients, with an emphasis on the safety of biological agents (mainly belimumab and rituximab) and traditional therapeutic regimens.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. IVIG: Current role in bone marrow transplant, malignancy, and immune hematologic disorders (1992) Symposium proceedings. Scottsdale, Arizona, October 10–13, 1990. Semin Hematol 29(3 Suppl 2):1–133

  2. Munroe ME, Vista ES, Merrill JT, Guthridge JM, Roberts VC, James JA (2017) Pathways of impending disease flare in African-American systemic lupus erythematosus patients. J Autoimmun 78:70–78

    Article  PubMed  PubMed Central  Google Scholar 

  3. Ayesha JV, Goswami D (2016) Premature Ovarian Failure: An Association with Autoimmune Diseases. J Clin Diagn Res 10(10):QC10–QC12

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Carp HJ, Selmi C, Shoenfeld Y (2012) The autoimmune bases of infertility and pregnancy loss. J Autoimmun 38(2–3):J266-274

    Article  CAS  PubMed  Google Scholar 

  5. Andreoli L, Bertsias GK, Agmon-Levin N, Brown S, Cervera R, Costedoat-Chalumeau N, Doria A, Fischer-Betz R, Forger F, Moraes-Fontes MF et al (2017) EULAR recommendations for women’s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum Dis 76(3):476–485

    Article  CAS  PubMed  Google Scholar 

  6. Hickman RA, Gordon C (2011) Causes and management of infertility in systemic lupus erythematosus. Rheumatol (Oxf) 50(9):1551–1558

    Article  Google Scholar 

  7. Berkun Y, Zandman-Goddard G, Barzilai O, Boaz M, Sherer Y, Larida B, Blank M, Anaya JM, Shoenfeld Y (2009) Infectious antibodies in systemic lupus erythematosus patients. Lupus 18(13):1129–1135

    Article  CAS  PubMed  Google Scholar 

  8. Khizroeva J, Nalli C, Bitsadze V, Lojacono A, Zatti S, Andreoli L, Tincani A, Shoenfeld Y, Makatsariya A (2019) Infertility in women with systemic autoimmune diseases. Best Pract Res Clin Endocrinol Metab 33(6):101369

    Article  CAS  PubMed  Google Scholar 

  9. Pasoto SG, Mendonca BB, Bonfa E (2002) Menstrual disturbances in patients with systemic lupus erythematosus without alkylating therapy: clinical, hormonal and therapeutic associations. Lupus 11(3):175–180

    Article  CAS  PubMed  Google Scholar 

  10. Luo W, Mao P, Zhang L, Chen X, Yang Z (2020) Assessment of ovarian reserve by serum anti-Mullerian hormone in patients with systemic lupus erythematosus: a meta-analysis. Ann Palliat Med 9(2):207–215

    Article  PubMed  Google Scholar 

  11. Salmon J, Girardi G, Lockshin M (2007) The antiphospholipid syndrome as a disorder initiated by inflammation: implications for the therapy of pregnant patients. Nature Clin Pract Rheumatol 3(3):140–147

    Article  CAS  Google Scholar 

  12. Dooley MA, Nair R (2008) Therapy Insight: preserving fertility in cyclophosphamide-treated patients with rheumatic disease. Nat Clin Pract Rheumatol 4(5):250–257

    Article  CAS  PubMed  Google Scholar 

  13. Vinet E, Pineau C, Gordon C, Clarke AE, Bernatsky S (2008) Systemic lupus erythematosus in women: impact on family size. Arthritis Rheum 59(11):1656–1660

    Article  PubMed  Google Scholar 

  14. Schmalzing M, Nau LF, Gernert M, Froehlich M, Schwaneck EC, Pecher AC, Saur S, Tony HP, Henes M, Henes J (2020) Sexual function in German women with systemic sclerosis compared to women with systemic lupus erythematosus and evaluation of a screening test. Clin Exp Rheumatol 125(3):59–64

    Google Scholar 

  15. Wagner SJ, Craici I, Reed D, Norby S, Bailey K, Wiste HJ, Wood CM, Moder KG, Liang KP, Liang KV et al (2009) Maternal and foetal outcomes in pregnant patients with active lupus nephritis. Lupus 18(4):342–347

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Vagelli R, Tani C, Mosca M (2017) Pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Practical messages from the EULAR guidelines. Pol Arch Intern Med 127(2):115–121

    PubMed  Google Scholar 

  17. Buyon JP, Clancy RM, Friedman DM (2009) Autoimmune associated congenital heart block: integration of clinical and research clues in the management of the maternal / foetal dyad at risk. J Intern Med 265(6):653–662

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Yazdany J, Trupin L, Kaiser R, Schmajuk G, Gillis JZ, Chakravarty E, Schwarz EB (2011) Contraceptive counseling and use among women with systemic lupus erythematosus: a gap in health care quality? Arthritis Care Res (Hoboken) 63(3):358–365

    PubMed  Google Scholar 

  19. Culwell KR, Curtis KM, del Carmen CM (2009) Safety of contraceptive method use among women with systemic lupus erythematosus: a systematic review. Obstet Gynecol 114(2 Pt 1):341–353

    Article  PubMed  Google Scholar 

  20. Gensous N, Doassans-Comby L, Lazaro E, Duffau P (2017) Systemic lupus erythematosus and contraception: a systematic literature review. Rev Med Interne 38(6):358–367

    Article  CAS  PubMed  Google Scholar 

  21. Sanchez-Guerrero J, Uribe AG, Jimenez-Santana L, Mestanza-Peralta M, Lara-Reyes P, Seuc AH, Cravioto MD (2005) A trial of contraceptive methods in women with systemic lupus erythematosus. N Engl J Med 353(24):2539–2549

    Article  CAS  PubMed  Google Scholar 

  22. Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, Lockshin M, Merrill JT, Belmont HM, Askanase AD et al (2005) Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 353(24):2550–2558

    Article  CAS  PubMed  Google Scholar 

  23. Jungers P, Dougados M, Pelissier C, Kuttenn F, Tron F, Lesavre P, Bach JF (1982) Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus. Arthritis Rheum 25(6):618–623

    Article  CAS  PubMed  Google Scholar 

  24. Mendel A, Bernatsky S, Pineau CA, St-Pierre Y, Hanly JG, Urowitz MB, Clarke AE, Romero-Diaz J, Gordon C, Bae SC et al (2019) Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen. Rheumatology 58(7):1259–1267

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Tektonidou MG, Andreoli L, Limper M, Amoura Z, Cervera R, Costedoat-Chalumeau N, Cuadrado MJ, Dorner T, Ferrer-Oliveras R, Hambly K et al (2019) EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis 78(10):1296–1304

    Article  CAS  PubMed  Google Scholar 

  26. Clowse ME, Jamison M, Myers E, James AH (2008) A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol 199(2):127

    Article  PubMed Central  Google Scholar 

  27. Dong Y, Yuan F, Dai Z, Wang Z, Zhu Y, Wang B (2020) Preeclampsia in systemic lupus erythematosus pregnancy: a systematic review and meta-analysis. Clin Rheumatol 39(2):319–325

    Article  PubMed  Google Scholar 

  28. Ugolini-Lopes MR, Torrezan GT, Gandara APR, Olivieri EHR, Nascimento IS, Okazaki E, Bonfa E, Carraro DM, de Andrade DCO (2019) Enhanced type I interferon gene signature in primary antiphospholipid syndrome: association with earlier disease onset and preeclampsia. Autoimmun Rev 18(4):393–398

    Article  CAS  PubMed  Google Scholar 

  29. Moroni G, Doria A, Giglio E, Imbasciati E, Tani C, Zen M, Strigini F, Zaina B, Tincani A, Gatto M et al (2016) Maternal outcome in pregnant women with lupus nephritis. A prospective multicenter study. J Autoimmun 74:194–200

    Article  PubMed  Google Scholar 

  30. Duley L, Henderson-Smart DJ, Meher S, King JF (2007) Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2:CD004659

    Google Scholar 

  31. Clowse ME, Magder LS, Witter F, Petri M (2005) The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum 52(2):514–521

    Article  PubMed  Google Scholar 

  32. Petri M (1997) Hopkins lupus pregnancy center: 1987 to 1996. Rheum Dis Clin North Am 23(1):1–13

    Article  CAS  PubMed  Google Scholar 

  33. Clark CA, Spitzer KA, Nadler JN, Laskin CA (2003) Preterm deliveries in women with systemic lupus erythematosus. J Rheumatol 30(10):2127–2132

    PubMed  Google Scholar 

  34. Yasmeen S, Wilkins EE, Field NT, Sheikh RA, Gilbert WM (2001) Pregnancy outcomes in women with systemic lupus erythematosus. J Matern Fetal Med 10(2):91–96

    Article  CAS  PubMed  Google Scholar 

  35. Johnson MJ, Petri M, Witter FR, Repke JT (1995) Evaluation of preterm delivery in a systemic lupus erythematosus pregnancy clinic. Obstet Gynecol 86(3):396–399

    Article  CAS  PubMed  Google Scholar 

  36. Cortes-Hernandez J, Ordi-Ros J, Paredes F, Casellas M, Castillo F, Vilardell-Tarres M (2002) Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies. Rheumatol (Oxf) 41(6):643–650

    Article  CAS  Google Scholar 

  37. Ozmen A, Unek G, Korgun ET (2017) Effect of glucocorticoids on mechanisms of placental angiogenesis. Placenta 52:41–48

    Article  CAS  PubMed  Google Scholar 

  38. Ignacchiti LM, Costa RB, de Ramires JG, Dos Cunha SF, de Ramires JN, Levy R, Mendes KE (2021) The association between active proliferative lupus nephritis during pregnancy and small for gestational age newborns. Clin Exp Rheumatol 39(5):1043–1048

    Article  Google Scholar 

  39. De Carolis S, Botta A, Santucci S, Salvi S, Moresi S, Di Pasquo E, Del Sordo G, Martino C (2012) Complementemia and obstetric outcome in pregnancy with antiphospholipid syndrome. Lupus 21(7):776–778

    Article  PubMed  Google Scholar 

  40. Petri M, Howard D, Repke J, Goldman DW (1992) The Hopkins Lupus Pregnancy Center: 1987–1991 update. Am J Reprod Immunol 28(3–4):188–191

    Article  CAS  PubMed  Google Scholar 

  41. Lee LA, Frank MB, McCubbin VR, Reichlin M (1994) Autoantibodies of neonatal lupus erythematosus. J Invest Dermatol 102(6):963–966

    Article  CAS  PubMed  Google Scholar 

  42. Izmirly PM, Saxena A, Kim MY, Wang D, Sahl SK, Llanos C, Friedman D, Buyon JP (2011) Maternal and fetal factors associated with mortality and morbidity in a multi-racial/ethnic registry of anti-SSA/Ro-associated cardiac neonatal lupus. Circulation 124(18):1927–1935

    Article  PubMed  PubMed Central  Google Scholar 

  43. Cimaz R, Spence DL, Hornberger L, Silverman ED (2003) Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-Ro autoantibodies. J Pediatr 142(6):678–683

    Article  PubMed  Google Scholar 

  44. Askanase AD, Friedman DM, Copel J, Dische MR, Dubin A, Starc TJ, Katholi MC, Buyon JP (2002) Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA/Ro-SSB/La antibodies. Lupus 11(3):145–151

    Article  CAS  PubMed  Google Scholar 

  45. Knight CL, Nelson-Piercy C (2017) Management of systemic lupus erythematosus during pregnancy: challenges and solutions. Open Access Rheumatol 9:37–53

    Article  PubMed  PubMed Central  Google Scholar 

  46. Keriakos R, Bhatta SR, Morris F, Mason S, Buckley S (2011) Pelvic girdle pain during pregnancy and puerperium. J Obstet Gynaecol 31(7):572–580

    Article  CAS  PubMed  Google Scholar 

  47. Gianfreda D, Quaglini S, Frontini G, Raffiotta F, Messa P, Moroni G (2017) Does pregnancy have any impact on long term damage accrual and on the outcome of lupus nephritis? J Autoimmun 84:46–54

    Article  PubMed  Google Scholar 

  48. Barbhaiya M, Bermas BL (2013) Evaluation and management of systemic lupus erythematosus and rheumatoid arthritis during pregnancy. Clin Immunol 149(2):225–235

    Article  CAS  PubMed  Google Scholar 

  49. Ko HS, Ahn HY, Jang DG, Choi SK, Park YG, Park IY, Lee G, Park SH, Shin JC (2011) Pregnancy outcomes and appropriate timing of pregnancy in 183 pregnancies in Korean patients with SLE. Int J Med Sci 8(7):577–583

    Article  PubMed  PubMed Central  Google Scholar 

  50. Imbasciati E, Tincani A, Gregorini G, Doria A, Moroni G, Cabiddu G, Marcelli D (2009) Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome. Nephrol Dial Transplant 24(2):519–525

    Article  PubMed  Google Scholar 

  51. Moroni G, Ponticelli C (2005) Pregnancy after lupus nephritis. Lupus 14(1):89–94

    Article  CAS  PubMed  Google Scholar 

  52. Yelnik CM, Laskin CA, Porter TF, Branch DW, Buyon JP, Guerra MM, Lockshin MD, Petri M, Merrill JT, Sammaritano LR et al (2016) Lupus anticoagulant is the main predictor of adverse pregnancy outcomes in aPL-positive patients: validation of PROMISSE study results. Lupus Sci Med 3(1):e000131

    Article  PubMed  PubMed Central  Google Scholar 

  53. Motta M, Tincani A, Faden D, Zinzini E, Lojacono A, Marchesi A, Frassi M, Biasini C, Zatti S, Chirico G (2005) Follow-up of infants exposed to hydroxychloroquine given to mothers during pregnancy and lactation. J Perinatol 25(2):86–89

    Article  CAS  PubMed  Google Scholar 

  54. Park-Wyllie L, Mazzotta P, Pastuszak A, Moretti ME, Beique L, Hunnisett L, Friesen MH, Jacobson S, Kasapinovic S, Chang D et al (2000) Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 62(6):385–392

    Article  CAS  PubMed  Google Scholar 

  55. Sammaritano LR, Bermas BL (2014) The medical management of the rheumatology patient during pregnancy. Springer, New York

    Google Scholar 

  56. Gotestam Skorpen C, Hoeltzenbein M, Tincani A, Fischer-Betz R, Elefant E, Chambers C, da Silva J, Nelson-Piercy C, Cetin I, Costedoat-Chalumeau N et al (2016) The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis 75(5):795–810

    Article  PubMed  Google Scholar 

  57. Hall JG, Pauli RM, Wilson KM (1980) Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 68(1):122–140

    Article  CAS  PubMed  Google Scholar 

  58. Galambosi PJ, Kaaja RJ, Stefanovic V, Ulander VM (2012) Safety of low-molecular-weight heparin during pregnancy: a retrospective controlled cohort study. Eur J Obstet Gynecol Reprod Biol 163(2):154–159

    Article  CAS  PubMed  Google Scholar 

  59. Clowse ME, Magder L, Witter F, Petri M (2006) Hydroxychloroquine in lupus pregnancy. Arthritis Rheum 54(11):3640–3647

    Article  PubMed  Google Scholar 

  60. ACOG Practice Bulletin No (2011) 118: antiphospholipid syndrome. Obstet Gynecol 117(1):192–199

    Article  Google Scholar 

  61. Limper M, Scire CA, Talarico R, Amoura Z, Avcin T, Basile M, Burmester G, Carli L, Cervera R, Costedoat-Chalumeau N et al (2018) Antiphospholipid syndrome: state of the art on clinical practice guidelines. RMD Open 4(Suppl 1):e000785

    Article  PubMed  PubMed Central  Google Scholar 

  62. Tunks RD, Clowse ME, Miller SG, Brancazio LR, Barker PC (2013) Maternal autoantibody levels in congenital heart block and potential prophylaxis with antiinflammatory agents. Am J Obstet Gynecol 208(1):64–67

    Article  Google Scholar 

  63. Alstead EM, Ritchie JK, Lennard-Jones JE, Farthing MJ, Clark ML (1990) Safety of azathioprine in pregnancy in inflammatory bowel disease. Gastroenterology 99(2):443–446

    Article  CAS  PubMed  Google Scholar 

  64. Bramham K, Chusney G, Lee J, Lightstone L, Nelson-Piercy C (2013) Breastfeeding and tacrolimus: serial monitoring in breast-fed and bottle-fed infants. Clin J Am Soc Nephrol 8(4):563–567

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Bar Oz B, Hackman R, Einarson T, Koren G (2001) Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis. Transplantation 71(8):1051–1055

    Article  CAS  PubMed  Google Scholar 

  66. Parke A (1992) The role of IVIG in the management of patients with antiphospholipid antibodies and recurrent pregnancy losses. Clin Rev Allergy 10(1–2):105–118

    CAS  PubMed  Google Scholar 

  67. Bag-Ozbek A, Hui-Yuen JS (2021) Emerging B-Cell Therapies in Systemic Lupus Erythematosus. Ther Clin Risk Manag 17:39–54

    Article  PubMed  PubMed Central  Google Scholar 

  68. Auyeung-Kim DJ, Devalaraja MN, Migone TS, Cai W, Chellman GJ (2009) Developmental and peri-postnatal study in cynomolgus monkeys with belimumab, a monoclonal antibody directed against B-lymphocyte stimulator. Reprod Toxicol 28(4):443–455

    Article  CAS  PubMed  Google Scholar 

  69. Wasserman S, Clowse MEB (2014) Systemic lupus erthematosus. In: Sammaritano LR, Bermas BL (eds) Contraception and pregnancy in patients with rheumatic disease. Springer, New York, pp 79–97

  70. Palmeira P, Quinello C, Silveira-Lessa AL, Zago CA, Carneiro-Sampaio M (2012) IgG placental transfer in healthy and pathological pregnancies. Clin Dev Immunol 2012:985646

    Article  PubMed  Google Scholar 

  71. Friedrichs B, Tiemann M, Salwender H, Verpoort K, Wenger MK, Schmitz N (2006) The effects of rituximab treatment during pregnancy on a neonate. Haematologica 91(10):1426–1427

    PubMed  Google Scholar 

Download references

Funding

The authors declare that no funds, grants, or other support were received during the preparation of this manuscript.

Author information

Authors and Affiliations

Authors

Contributions

SZ: Manuscript writing, Providing the idea for the article, Literature search and management. XH: Literature search. WL: Literature search. QW: Literature search. JW: Manuscript editing, Project development. All authors contributed to the study conception. The first draft of the manuscript was written by SZ and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Jibo Wang.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, S., Han, X., Liu, W. et al. Pregnancy in patients with systemic lupus erythematosus: a systematic review. Arch Gynecol Obstet 308, 63–71 (2023). https://doi.org/10.1007/s00404-022-06718-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-022-06718-7

Keywords

Navigation